ArticleDeutsche medizinische Wochenschrift (1946)2014

[Do antibodies provide advantages for the therapy of Alzheimer's disease? Solanezumab: the jury is still out].

Oliver PetersPubMed ↗Publisher ↗

No numbers read from the abstract.